Literature DB >> 17555657

[Pneumococcal vaccination in the over-65 population].

Angel Vila Córcoles.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17555657      PMCID： PMC7664530          DOI： 10.1157/13106279

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  11 in total

Review 1.  Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence.

Authors:  Punam Mangtani; Felicity Cutts; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2003-02       Impact factor: 25.071

2.  Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.

Authors:  Angel Vila-Córcoles; Olga Ochoa-Gondar; Imma Hospital; Xabier Ansa; Angels Vilanova; Teresa Rodríguez; Carl Llor
Journal:  Clin Infect Dis       Date:  2006-08-21       Impact factor: 9.079

Review 3.  [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis].

Authors:  J Puig-Barberà; A Belenguer Varea; M Goterris Pinto; M J Brines Benlliure
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

4.  Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.

Authors:  Angela Dominguez; Lluis Salleras; David S Fedson; Conchita Izquierdo; Laura Ruiz; Pilar Ciruela; Asuncion Fenoll; Julio Casal
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

5.  Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Authors:  Lisa A Jackson; Kathleen M Neuzil; Onchee Yu; Patti Benson; William E Barlow; Annette L Adams; Christi A Hanson; Lisa D Mahoney; David K Shay; William W Thompson
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

Review 6.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

7.  The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

Authors:  Alessia Melegaro; W John Edmunds
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 8.  Vaccines for preventing pneumococcal infection in adults.

Authors:  K Dear; J Holden; R Andrews; D Tatham
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults.

Authors:  David S Fedson; Charles Liss
Journal:  Vaccine       Date:  2004-02-25       Impact factor: 3.641

10.  [EVAN-65 project: evaluation of the effectiveness of pneumococcus vaccination in the elderly population over 65].

Authors:  A Vila Córcoles; O Ochoa Gondar; I Hospital Guardiola; X Bria Ferre; C Llor Vila; D Montañes Boncompte
Journal:  Aten Primaria       Date:  2004-02-28       Impact factor: 1.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.